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Mutations in Pkd1, encoding polycystin-1 (PC1),
cause autosomal-dominant polycystic kidney dis-
ease (ADPKD). We show that the carboxy-terminal
tail (CTT) of PC1 is releasedby g-secretase-mediated
cleavage and regulates theWnt and CHOP pathways
by binding the transcription factors TCF and CHOP,
disrupting their interaction with the common tran-
scriptional coactivator p300. Loss of PC1 causes
increased proliferation and apoptosis, while reintro-
ducingPC1-CTT intoculturedPkd1null cells reestab-
lishes normal growth rate, suppresses apoptosis,
andprevents cyst formation. Inhibitionofg-secretase
activity impairs the ability of PC1 to suppress growth
and apoptosis and leads to cyst formation in cultured
renal epithelial cells. Expression of the PC1-CTT is
sufficient to rescue the dorsal body curvature pheno-
type in zebrafish embryos resulting fromeitherg-sec-
retase inhibition or suppression of Pkd1 expression.
Thus, g-secretase-dependent release of the PC1-
CTT creates a protein fragment whose expression is
sufficient to suppress ADPKD-related phenotypes
in vitro and in vivo.
INTRODUCTION
Autosomal-dominant polycystic kidney disease (ADPKD), a
common genetic disorder, produces fluid-filled renal cysts that
disrupt the normal tubular architecture and can ultimately lead
to kidney failure (Wilson, 2004). Most cases (85%) result from
mutations in the gene encoding polycystin-1 (Pkd1), with the
remaining 15% resulting from mutations in the gene encoding
polycystin-2 (Pkd2) (Harris and Torres, 2009; Rossetti et al.,
2007). Polycystin-1 (PC1) has a large extracellular domain, 11
transmembrane spans, and a short carboxy-terminal cyto-Developmplasmic tail (Hughes et al., 1995). The PC1 C-terminal tail
(PC1-CTT) has been implicated in the regulation of several
signaling pathways, including Wnt (Kim et al., 1999; Lal et al.,
2008; Zhang et al., 2007), mTOR (Shillingford et al., 2006), p21/
JAK/STAT (Bhunia et al., 2002; Low et al., 2006; Talbot et al.,
2011), and activator protein-1 (Arnould et al., 1998; Chauvet
et al., 2004; Parnell et al., 2002). Polycystin-2 is a nonselective
calcium-permeable cation channel that interacts and forms
a complex with PC1 via the coiled-coil domains present in
each of these proteins (Qian et al., 1997).
PC1 is subject to several proteolytic cleavages (Chapin and
Caplan, 2010; Woodward et al., 2010), including an autocatalytic
event that releases the N-terminal extracellular domain, which
remains noncovalently associated with the transmembrane
domains (Qian et al., 2002). The PC1-CTT is cleaved and trans-
locates to the nucleus (Bertuccio et al., 2009; Chauvet et al.,
2004; Low et al., 2006; Talbot et al., 2011). Nuclear PC1-CTT
regulates cell-signaling pathways, including activation of
STAT6/P100 and STAT3 (Low et al., 2006; Talbot et al., 2011),
and inhibition of b-catenin-mediated canonical Wnt signaling
(Lal et al., 2008). ADPKD cyst formation is thought to occur, at
least in part, as a result of dysregulation of epithelial cell prolifer-
ation and of apoptosis (Chapin and Caplan, 2010; Lanoix et al.,
1996; Shibazaki et al., 2008; Starremans et al., 2008; Takiar
and Caplan, 2011).
We show that the CTT of PC1 is released by a g-secretase-
dependent cleavage and translocates to the nucleus, where it
regulates transcriptional pathways involved in proliferation and
apoptosis. Expression of the CTT fragment corrects several of
the growth andmorphogenesis-related phenotypes that charac-
terize Pkd1 null cells grown in three-dimensional (3D) culture.
Furthermore, expression of the PC1-CTT rescues the dorsal
body curvature that is produced both by inhibition of PC1
expression and by inhibition of g-secretase activity in zebrafish.
Finally, we provide evidence establishing a commonmechanism
for PC1-CTT inhibition of proproliferative and proapoptotic
signaling pathways through disruption of the relevant transcrip-
tion factors’ interactions with the transcriptional coactivator
p300.ental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc. 197
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Loss of PC1 in Mouse Renal Epithelial Cells Causes
Increased Proliferation, Apoptosis, and Cyst
Development in 3D Cell Culture
Clonal renal tubular epithelial cell lines derived from Pkd1flox/
mice were transfected with Cre recombinase to generate
Pkd1/ cells (Joly et al., 2006; Shibazaki et al., 2008). These
cell lines, which are genetically identical except for the deletion
of both copies of the gene encoding PC1 in the Pkd1/ cells,
produced strikingly different multicellular structures when grown
in 3D culture. Pkd1flox/ cells grew into extended, tubule-like
structures, whereas the Pkd1/ cells developed into large,
spherical cysts with hollow central lumens (Figure 1A). This can
be seen graphically in time-lapse videos of Pkd1flox/ and
Pkd1/ cells grown in 3D culture (see Movies S1, S2, and S3
available online). The Pkd1/ cells acquire a hollow central
lumen within the first several days of culture, whereas the
Pkd1flox/ cells slowly form linear tubule-like structures.
Pkd1/ cells displayed higher levels of proliferation as
compared to Pkd1flox/ cells, as measured by BrdU incorpora-
tion (Figure 1B). Apoptosis, as measured by staining for cleaved
caspase-3, was virtually undetectable in the Pkd1flox/ cells,
whereas apoptosis was evident in the Pkd1/ cells, both in
cyst-lining cells (Figure 1B, arrowheads) and at the center of
cell aggregates that had yet to develop a hollow central lumen
(Figure 1B, inset).
To determine the effect of the isolated PC1-CTT on cystogen-
esis, PC1-CTT was conditionally expressed under the control of
doxycycline using a TET-Off inducible expression system in
a stably transfected Pkd1/ cell line. Pkd1/ cells induced to
express PC1-CTT displayed decreased levels of proliferation,
as measured by BrdU incorporation. In addition, expression of
PC1-CTT in the Pkd1/ cells resulted in a dramatic change in
the morphology of the structures they formed in 3D culture.
Instead of large, hollow-lumen, cyst-like structures, the Pkd1/
cells that express the PC1-CTT developed into branched tubule-
like structures lacking a hollow central lumen (Figure 1C). The
average sizes of the structures formed by the Pkd1/ cells
that express the PC1-CTT were similar to those measured for
the parental Pkd1flox/ cells, and these structures were signifi-
cantly smaller than the cystic structures formed by the Pkd1/
cells (Figures 1D and 1E). Immunostaining performed with an
antibody directed against the HA epitope appended to the
PC1-CTT construct demonstrates that these small cell clusters
and tubule-like structures do indeed express the exogenous
PC1-CTT protein (shown in red in Figure 1C and in gray scale
in the lower right panel of Figure 1D) and that the PC1-CTT
protein is concentrated in the nucleus (Figure S1).
The CTT Cleavage of PC1 Is Dependent upon
g-Secretase
C-terminal cleavage of PC1 was detected in HEK cells trans-
fected with a cDNA construct encoding full-length PC1 tagged
at the C terminus with the DNA-binding domain of Gal4 (Bertuc-
cio et al., 2009). Cleavage of PC1 allows the released CTT-Gal4
to translocate to the nucleus and to stimulate luciferase produc-
tion from a cotransfected UAS-Luciferase reporter plasmid.
Assays are performed in the presence of clasto-lactacystin, to198 Developmental Cell 22, 197–210, January 17, 2012 ª2012 Elseviprevent proteasome degradation of the cleaved PC1-CTT
(Bertuccio et al., 2009). The g-secretase inhibitor DAPT was
added to the media after transfection, and the cells were incu-
bated for 24 hr (Shearman et al., 2000). PC1 cleavage, as mea-
sured by Gal4-driven luciferase expression, was inhibited in
a dose-dependent manner by DAPT, indicating that PC1-CTT
cleavage is dependent upon g-secretase activity (Figure 2A).
Further evidence for g-secretase-dependent cleavage of PC1
was obtained through DAPT treatment of LLC-PK1 cells stably
expressing a full-length PC1 construct that carries a C-terminal
HA tag. Lysates from cells treated with clasto-lactacystin (to
prevent proteasome degradation of cleaved PC1 fragments)
were fractionated to separate nuclei from cytoplasm, and the
resultant fractions were analyzed by immunoblot. Bands corre-
sponding to the cleaved PC1-CTT were detected predominantly
in the nuclear fractions, and the intensity of this complex of bands
was significantly decreased in cells exposed toDAPT (Figure 2B).
We used siRNA to knock down expression in HEK293 cells of
Presenilin-1 or Presenilin-2, each of which can serve as the cata-
lytic subunit of the functional g-secretase complex. Loss of Pre-
senilin-1 did not decrease PC1-CTT cleavage as measured by
the PC1-GalVP cleavage assay (Figure 2C, left panels). Preseni-
lin-2 knockdown, however, resulted in a significant decrease in
PC1-CTT cleavage (Figure 2C, right panels) and a reduction in
the nuclear accumulation of PC1 cleavage products (Figure S2).
We next wished to determine whether g-secretase-mediated
cleavage of PC1 is required for the PC1 protein to exert its effects
on epithelial morphogenesis. Pkd1flox/ cells cultured in 3D were
treatedwith either DMSO vehicle or with DAPT for 10 days. DAPT
treatment resulted in a significant change in morphology in the
Pkd1flox/ cells. Whereas DMSO-treated cells formed linear
tubule-like structures, DAPT-treated cells formed spherical
cyst-like structures with hollow central lumens (Figure 2D, left
panels) reminiscent of the structures formed by the Pkd1/
cells. DAPT treatment had no significant effect on the mor-
phology of Pkd1/ cells (Figure 2D, right panels).
Expression of PC1-CTTResults in Reduced Proliferation
and Apoptosis in Pkd1–/– Cells
To quantify the effects observed in the 3D cell culture system,
Pkd1flox/ and Pkd1/ cells were cultured in two dimensions
on glass coverslips, and BrdU incorporation (Figure 3A) and
cleaved caspase-3 staining (Figure S3) were assessed as
measures of proliferation and apoptosis, respectively. Pkd1/
cells displayed a significantly higher level of proliferation than
Pkd1flox/ controls. However, reintroduction of the isolated
PC1-CTT significantly reduced proliferation of the Pkd1/ cells
to levels similar to those observed in Pkd1flox/ cells (Figure 3B).
Similarly, Pkd1/ cells displayed a significantly higher level of
apoptosis when compared to Pkd1flox/ controls. When PC1-
CTT expression was induced in Pkd1/ cells, the level of
apoptosis decreased significantly. Expression of PC1-CTT in
the Pkd1/ cells reduced apoptosis to levels similar to those
seen in the Pkd1flox/ cells (Figure 3C; Figure S3).
PC1-CTT Directly Interacts with TCF and Inhibits
Canonical Wnt Signaling
Previous data implicate canonical Wnt signaling as a driver of
cyst proliferation. Recent studies show activation of Wnt targeter Inc.
Figure 1. Pkd1 Knockout Results in Increased Proliferation, Apoptosis, and Cystic Morphology
(A) Phase-contrast imaging of Pkd1flox/ and Pkd1/ cells grown in 3D Matrigel matrix for 10 days.
(B) Pkd1flox/ and Pkd1/ structures were incubated with BrdU, fixed, and stained with a-BrdU-FITC (green) and a-cleaved caspase-3 (red). Nuclei were
counterstained with Hoechst 33342 (blue). The inset depicts a cell aggregate that had yet to develop a hollow central lumen.
(C)Pkd1/ cells stably expressing HA-PC1-CTT were grown in 3DMatrigel matrix for 10 days, exposed to BrdU, fixed, and stained with a-BrdU-FITC (green) and
a-HA (red) to detect expression of the HA-PC1-CTT. Nuclei were counterstained with Hoechst 33342 (blue). Cellular structures were imaged on a Leica confocal
microscope using a 403 objective.
(D) The top two panels show Pkd1flox/ and Pkd1/ cells that were grown in 3D Matrigel matrix for 7 days, incubated with BrdU, and then stained with a-BrdU
(green). Nuclei were counterstained with Hoechst 33342 (blue). The bottom two panels show Pkd1/ cells stably expressing HA-PC1-CTT that were grown in 3D
Matrigel matrix for 7 days, incubated with BrdU, and then stained with a-BrdU (green). Nuclei were counterstained with Hoechst 33342 (blue, left), and CTT
expression was detected with a-HA (gray, right).
(E) Plot of cross-sectional area of cellular structures pictured in (D). Bars indicate mean area in pixels: Pkd1flox/ = 185, Pkd1/ = 447, Pkd1/ HA-PC1-CTT =
163, n = 1,000 for each condition.
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demonstrate an interaction between the PC1-CTT and compo-
nents of the Wnt-signaling pathway (Kim et al., 1999; Lal et al.,
2008; Zhang et al., 2007). The Wnt pathway regulates the sizeDevelopmand activity of the cytosolic pool of b-catenin. At the cell
membrane, b-catenin is bound by E-cadherin. In resting polar-
ized epithelial cells, b-catenin is predominantly sequestered at
the basolateral plasma membrane, where it participates in theental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc. 199
Figure 2. PC1-CTT Cleavage Is Sensitive to the g-Secretase Inhibitor DAPT
(A) HEK293 cells transfectedwith PC1-GalVP, UAS-Luciferase, andRenilla were treatedwith the g-secretase inhibitor DAPT at the indicated concentrations in the
presence of clasto-lactacystin for 24 hr prior to quantification of the luciferase signal.
(B) LLC-PK1 cells stably expressing full-length PC1 with a C-terminal 23 HA tag were exposed to DAPT for 24 hr, in the presence of clasto-lactacystin, before
nuclear/cytoplasmic fractionation. Proteins were separated on a 10% SDS-polyacrylamide gel and analyzed by immunoblot. Nuclear purification was assessed
using a-RNA-Pol II (nuclear fraction) and a-calnexin (nonnuclear fraction). PC1-CTT cleavage fragments were detected using a-HA.
(C) HEK293 cells were transfected with either siControl (nontargeting RNA) or siRNA directed against human Presenilin-1 or Presenilin-2. qRT-PCR was used to
determine knockdown efficiency. PC1-GalVP, UAS-Luciferase, andRenilla were super-transfected into HEK cells after 48 hr of siRNA treatment to report on PC1-
CTT cleavage. Data aremean ± SE of four replicates each from two independent experiments. The data in all four panels are normalized to the siControl condition.
(D) Pkd1flox/ and Pkd1/ cells were cultured in 3D Matrigel matrix for 10 days in media containing either DMSO (vehicle control) or 100 mM DAPT, after which
they were fixed and imaged on a phase-contrast microscope.
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cytoplasmic b-catenin is recognized by a ‘‘destruction complex’’
that mediates its phosphorylation, targeting it for proteosomal
degradation. Activation of Wnt signaling prevents the destruc-
tion of free cytosolic b-catenin, which enters the nucleus to serve200 Developmental Cell 22, 197–210, January 17, 2012 ª2012 Elsevias a coactivator of the TCF transcription factor and thus induces
proliferation (Daugherty and Gottardi, 2007). To measure endog-
enous Wnt-signaling activity, we employed the TopFlash assay,
which utilizes a TCF-binding promoter element to drive expres-
sion of a luciferase reporter (van de Wetering et al., 1997).er Inc.
Figure 3. Effects of PC1-CTT Expression on Proliferation and Apoptosis
(A) Pkd1flox/ and Pkd1/ cells stably expressing HA-PC1-CTT encoded by a TET-Off inducible vector were grown on coverslips. PC1-CTT expression was
induced in the Pkd1/ cell line by withdrawal of doxycycline for 48 hr prior to BrdU exposure and fixation. Proliferating cells were labeled with a-BrdU-FITC
(green), PC1-CTT expression was detected with a-HA (red), and nuclei were counterstained with Hoechst 33342 (blue).
(B) Proliferation was quantified using automated cell-counting software. Expression of PC1-CTT in Pkd1/ cells resulted in a reduction of proliferation to levels
approaching those observed in the Pkd1flox/ cells.
(C) Apoptosis was assessed by staining with an antibody directed against cleaved caspase-3 (Figure S3) and quantified using automated cell-counting software.
Expression of PC1-CTT in Pkd1/ cells resulted in a reduction in apoptosis to levels similar to those seen in the Pkd1flox/ cells. Data are mean ± SE of ten fields
each from three independent experiments.
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activity than did the Pkd1flox/ controls. Furthermore, expression
of PC1-CTT in the Pkd1/ cells resulted in a significant reduc-
tion in the TopFlash luciferase activity to levels similar to those
detected in Pkd1flox/ cells (Figure 4A). This activity is dependent
upon the presence of the PC1-CTT nuclear localization
sequence (NLS), as evidenced by the fact that a PC1-CTT
construct lacking the NLS (PC1-CTT-DNLS) (Chauvet et al.,
2004) does not exert any inhibitory influence on TopFlash activityDevelopm(Lal et al., 2008; Figure 4B). Although the PC1-CTT-DNLS
construct does not alter TopFlash activity, it is worth noting
that this construct is able to produce a significant signal in
a reporter assay thatmeasures the activity of the STAT6 pathway
(Figure 4C). These data, which are consistent with previous
observations indicating that portions of the PC1-CTT can acti-
vate STAT6 signaling (Low et al., 2006), demonstrate that loss
of the NLS selectively blocks some but not all of the functional
activities of the PC1-CTT.ental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc. 201
Figure 4. TopFlash Activity Is Elevated in Pkd1–/– Cells and Inhibited by PC1-CTT Expression
(A) Pkd1flox/ and Pkd1/ cells stably expressing HA-PC1-CTT in a TET-Off inducible vector were transfected with TopFlash and Renilla luciferase reporter
constructs in the presence or absence of doxycycline, and luciferase activity was measured 24 hr later.
(B) TopFlash activity is significantly inhibited by expression of the PC1-CTT in HEK293 cells. Expression of the PC1-CTTDNLS does not inhibit TopFlash activity.
(C) HEK293 cells were transfected with a luciferase reporter construct driven by a STAT6-responsive promoter, as a measure of STAT6 activation. Expression of
exogenous STAT6, or PC1-CTTDNLS results in a significant activation of STAT6 promoter-driven luciferase production.
(D) Pkd1flox/ and Pkd1/ cells were transfected with TopFlash and Renilla luciferase reporter constructs and exposed to the g-secretase inhibitor DAPT for 24 hr
prior to quantification of luciferase signal. Data are mean ± SE of four replicates each from three independent experiments.
(E) GST-tagged constructs corresponding to the b-catenin-binding domain of TCF, E-cadherin CTT, and b-catenin were coexpressed with His-tagged PC1-CTT
in bacteria. When precipitated with glutathione beads, the PC1-CTT displays a strong direct interaction with TCF, and little direct interaction with E-cadherin or
b-catenin.
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tory effect of PC1 expression on TopFlash activity, consistent
with the hypothesis that PC1-CTT cleavage and nuclear
translocation of the released CTT fragment are necessary for
its inhibitory effect on TCF. DAPT treatment of Pkd1/ cells
did not stimulate any further increase in TopFlash activity, indi-
cating that the increase in Wnt activity obtained through inhibi-
tion of g-secretase is dependent on the presence of PC1
(Figure 4D).202 Developmental Cell 22, 197–210, January 17, 2012 ª2012 ElseviTo dissect further the elements of the canonical Wnt-
signaling pathway that interact directly with PC1-CTT, a bacte-
rial coexpression system was employed to drive simultaneous
expression of a His-tagged PC1-CTT and of GST-tagged
polypeptides incorporating the sequences of b-catenin, the
E-cadherin cytoplasmic domain, or TCF. When bacterial lysates
were subjected to glutathione-Sepharose pull-down and the
recovered proteins were blotted with anti-His antibody, PC1-
CTT exhibited little direct interaction with b-catenin or wither Inc.
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TCF (Figure 4C).
PC1-CTT Interacts with CHOP and Inhibits Its Activity
Data suggesting that the PC1-CTT may regulate apoptosis
(Figures 1 and 3; Figure S3) led us to search for novel regulatory
targets that couldmediate this influence. To identify transcription
factors regulated byPC1-CTT,we employed a ‘‘coactivator trap’’
screen, in which over 800 transcription factors are fused to the
DNA-binding domain of Gal4 (Amelio et al., 2007). After
cotransfection of each transcription factor-Gal4 construct and
a Gal4-driven luciferase reporter vector into HEK293 cells,
luciferase assays established baseline activities for each tran-
scription factor. PC1-CTTwas then cotransfected, and any effect
of PC1-CTT on each transcription factor’s activity wasmeasured
as a change in luciferase production as compared to its baseline
level. Several transcription factors were found to be significantly
regulated in the presence of PC1-CTT. One of the most
profoundly affected was CHOP-10/GADD153, which induces
apoptosis in response to ER stress as part of the unfolded protein
response (UPR) (Oyadomari and Mori, 2004) (Table S1).
Tomeasure the effects of full-length PC1 expression on CHOP
activation,Pkd1flox/ andPkd1/ cells were transfectedwith the
CHOP-Gal4 and the Gal4-luciferase reporter constructs.
Pkd1/ cells displayed significantly higher levels of CHOP
activity when compared to the Pkd1flox/ cells. Expression of
the soluble PC1-CTT in the Pkd1/ cells resulted in a significant
inhibition of CHOP-Gal4 activity (Figure 5A). In addition, treat-
ment of Pkd1flox/ cells with DAPT abolished the inhibitory effect
that PC1 expression exerts on CHOP-Gal4 activity. DAPT treat-
ment of Pkd1/ cells did not stimulate a further elevation in
CHOP activity, indicating that the increase in CHOP activity ob-
tained through inhibition of g-secretase-dependent protein
cleavage is dependent on the presence of PC1 (Figure 5B).
Thus, the presence of the PC1 protein acts, via its released
CTT, to negatively regulate CHOP activity. Once again, this
activity is dependent upon the presence of the PC1-CTT NLS
because the PC1-CTT-DNLS construct does not exert any inhib-
itory influence on CHOP activity (Figure 5C). To determine
whether the increased rate of apoptosis observed in the Pkd1/
cells is indeed a consequence of CHOP activity, Pkd1/ and
Pkd1flox/ cells were subjected to siRNA-mediated knockdown
of CHOP expression. Apoptosis was scored by staining for
cleaved caspase-3 (Figure 5D). Consistent with the data shown
in Figure 3C, the apoptotic rate manifest by the Pkd1/ cells
transfected with a control siRNA was twice that observed for the
similarly treated Pkd1flox/ cells. Whereas knockdown of CHOP
expression had no effect on the apoptotic rate observed in the
Pkd1flox/ cells, treatment with the CHOP siRNA reduced
the apoptotic rate in the Pkd1/ cells to the level measured
in the Pkd1flox/ cells. Taken together, these data demonstrate
that PC1 reduces CHOP activity in a cleavage-dependent
manner, and that elevated CHOP activity accounts for the
increased apoptosis that is measured in cells that lack PC1
expression.
To assess the possibility of a physical interaction between
CHOP and the PC1-CTT, HEK cells were transfected with
constructs encoding HA-PC1-CTT and a FLAG-tagged CHOP
protein. Lysates prepared from these cells were subjectedDevelopmto immunoprecipitation with anti-HA beads. CHOP coprecipi-
tated with the soluble PC1-CTT construct (Figure 5E). This
interaction was further validated by immunoprecipitation exper-
iments performed on lysates of nuclear fractions prepared from
LLC-PK1 cells stably expressing a full-length PC1 that carries
a C-terminal HA tag (Chapin et al., 2010). The endogenously
cleaved PC1-CTT released from the full-length PC1 protein
coprecipitated with nuclear CHOP (Figure 5F).
PC1-CTT Inhibits TCF andCHOPActivities by Disrupting
Their Interactions with p300
Although TCF and CHOP activate discrete transcriptional path-
ways, they both utilize and depend upon the common transcrip-
tional coactivator, p300/CBP (Li et al., 2007; Ohoka et al., 2007).
To determine the potential importance of p300 in the PC1-CTT-
mediated regulation of TCF and CHOP, HEK cells were trans-
fected with PC1-CTT alone, or in the presence of overexpressed
p300. As shown previously, PC1-CTT expression inhibits TCF
activity (as assessed by TopFlash assay) in the context of native
levels of p300 protein expression (Lal et al., 2008). Overexpres-
sion of p300 eliminated this inhibitory effect of PC1-CTT, sug-
gesting that this inhibitory effect is achieved through competition
between the PC1-CTT and p300 for binding to TCF (Figure 6A).
To test this possibility directly, TCF and CHOP were precipi-
tated from HEK cells transfected with p300 and PC1-CTT
(Figures 6B and 6D). As expected, in the absence of PC1-CTT,
TCF and CHOP each coprecipitates with p300 (Hecht and
Stemmler, 2003; Ohoka et al., 2007). These interactions were
significantly disrupted in cells that express PC1-CTT, suggesting
that the CTT of PC1 exerts its inhibitory effect on the activities of
TCF and CHOP by interfering with their interactions with p300
(Figures 6B–6E).
PC1-CTT Rescues Morphant Phenotypes
in Pkd1-Knockdown Zebrafish Embryos
Morpholino-induced knockdown of the two zebrafish Pkd1
genes, Pkd1a and Pkd1b, produces dorsal body axis curva-
ture, kidney cysts, hydrocephalus, and skeletal abnormalities
(Mangos et al., 2010). Of these findings, the dorsal body curva-
ture was considered to be the most reliable marker of Pkd1
knockdown, due to the substantially higher penetrance of this
phenotype. Interestingly, treatment of zebrafish embryos with
the g-secretase inhibitor DAPT produces a similar phenotype,
characterized by mild and moderate dorsal axis curvature
(Arslanova et al., 2010). To determine the capacity of the PC1-
CTT to rescue the phenotype associated with impaired Pkd1
gene expression in vivo, zebrafish embryos were injected with
Pkd1a/b morpholinos alone, or with mRNA encoding the PC1-
CTT. Knockdown of Pkd1a/b results in dorsal axis curvature,
whereas concurrent injection of the PC1-CTT significantly
decreases the severity of the body curvature at 3 dpf (Figures
7A and 7B). Injection of mRNA encoding the PC1-CTT-DNLS
construct did not rescue the body curvature phenotype (Figures
S4A and S4B). A subset of the signaling pathways influenced by
the PC1-CTT requires the NLS (Wnt and CHOP), whereas others
appear to not require the presence of this motif (e.g., STAT-6)
(Figures 4B, 4C, and 5C). Thus, these data suggest that the
capacity of the PC1-CTT to ameliorate the severity of the body
curvature phenotype involves one ormore of theNLS-dependentental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc. 203
Figure 5. CHOP-Gal4 Activity Is Elevated in Pkd1–/– Cells and Inhibited by PC1-CTT Expression
(A) Pkd1flox/ and Pkd1/ cells stably expressing HA-PC1-CTT in a TET-Off inducible vector were transfected with CHOP-Gal4, UAS-Luciferase, and Renilla
luciferase reporter constructs in the presence or absence of doxycycline, and luciferase activity was measured 24 hr later.
(B) Pkd1flox/ and Pkd1/ cells were transfected with CHOP-Gal4, UAS-Luciferase, and Renilla luciferase reporter constructs and exposed to the g-secretase
inhibitor DAPT for 24 hr prior to quantification of luciferase signal. Data are mean ± SE of four replicates each from three independent experiments.
(C) CHOP-Gal4 activity is significantly inhibited by expression of the PC1-CTT in HEK293 cells, whereas it is not inhibited in the presence of the PC1-CTTDNLS.
(D) Pkd1flox/ and Pkd1/ cells were reverse transfected with either noncoding siRNA (siControl), or siRNA corresponding to CHOP (siCHOP), and apoptosis
levels were measured 48 hr later by cleaved caspase-3 staining.
(E) HEK293 cells were cotransfected with CHOP-Gal4 and HA-PC1-CTT. Cell lysates were subjected to immunoprecipitation using a-HA Sepharose, and the
immunoprecipitates were then blotted with the indicated antibodies.
(F) LLC-PK1 cells stably expressing full-length PC1 with a C-terminal 23 HA tag were transfected with FLAG-CHOP, and subjected to nuclear/cytoplasmic
fractionation. Endogenously cleaved PC1-CTT was immunoprecipitated from the nuclear fraction using a-HA Sepharose, and the resulting complexes were
separated on a 10% polyacrylamide gel and blotted with the indicated antibodies.
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injection of mRNA encoding the PC1-CTT, but not mRNA encod-
ing control GFP, partially rescued the body curvature phenotype
induced by DAPT treatment, producing a significant increase in
the percentage of fish with straight bodies and a decrease in
the percentage of moderately curved fish (Figure 7C).204 Developmental Cell 22, 197–210, January 17, 2012 ª2012 ElseviDISCUSSION
Our data confirm the role of PC1 as an inhibitor of renal
epithelial cell proliferation and apoptosis, and provide evi-
dence for the mechanism responsible for this regulation, medi-
ated by cleavage and nuclear translocation of the PC1-CTT.er Inc.
Figure 6. PC1-CTT Competitively Disrupts the Interaction of TCF and CHOP with p300
(A) HEK293 cells were transfected with TopFlash and Renilla luciferase reporter constructs, along with PC1-CTT alone or with PC1-CTT and a construct driving
overexpression of full-length p300. NS, not significant.
(B) HEK293 cells were transfected with Myc-p300, and with HA-PC1-CTT where indicated. Cell lysates were incubated with glutathione beads prebound with
GST-TCF. Recovered complexes were eluted in SDS-PAGE loading buffer, run on a 10% SDS-polyacrylamide gel, and blotted with the indicated antibodies.
(C and E) Band densitometry was performed using image analysis software to quantitate the data from the coprecipitation experiments shown in (B) and (D).
Results are expressed as mean ± SE from four independent experiments.
(D) HEK293 cells were transfected with Myc-p300, FLAG-CHOP, and with HA-PC1-CTT where indicated. Cell lysates were incubated with a-FLAG prebound to
agarose beads to precipitate CHOP, and the recovered complexes were eluted in SDS-PAGE loading buffer, run on a 10% SDS- polyacrylamide gel, and blotted
with the indicated antibodies.
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g-Secretase Cleavage of PC1 Regulates TCF and CHOPReintroduction of the PC1-CTT into Pkd1 knockout cells is suffi-
cient to normalize their excessive proliferative and apoptotic
activities, and the PC1-CTT is sufficient to rescue the dorsal
tail curvature phenotype produced by morpholino-mediated
disruption of Pkd1a/b expression in zebrafish. We show that
PC1 cleavage is dependent upon g-secretase activity, and that
the released PC1-CTT inhibits TCF and CHOP, thereby regu-
lating proliferation and apoptosis, respectively. Furthermore,
injection of mRNA encoding the PC1-CTT is capable of partially
rescuing the dorsal tail curvature phenotype produced by expo-Developmsure of zebrafish embryos to the g-secretase inhibitor DAPT. The
similarity of the phenotypes produced byPkd1a/b disruption and
DAPT treatment is intriguing, and the ability of the PC1-CTT to
partially rescue both suggests that at least some of the critical
biological activities of the PC1 protein are dependent upon its
g-secretase-dependent PC1-CTT cleavage. Finally, we demon-
strate that PC1-CTT inhibits TCF and CHOP by disrupting their
interaction with the transcriptional coactivator p300, illustrating
a common mechanism through which PC1-CTT is capable of
regulating two distinct transcriptional pathways.ental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc. 205
Figure 7. Both Morpholino Knockdown of Pkd1a/b
and Treatment with DAPT Result in Dorsal Axis
Curvature in Zebrafish Embryos, which Can Be
Rescued by Expression of the PC1-CTT
(A) Morpholinos corresponding to the zebrafish Pkd1a and
Pkd1b PC1 genes were injected into zebrafish embryos at
the one- to two-cell stage to impair expression of the two
Pkd1 genes. The embryos were subsequently injected
with 300 nM of mRNA encoding HA-PC1-CTT, where
indicated, and imaged at 3 days post fertilization (dpf).
(B) Embryo phenotypes were scored based on the degree
of dorsal tail curvature: mild (<90), moderate (>90), and
severe (tail tip crossing the body axis). The data represent
the averages of three separate experiments; error bars
represent SEM.
(C) Embryos were injected with 300 nM mRNA encoding
either GFP (control) or HA-PC1-CTT at the one- to two-cell
stage, then immersed in embryo media containing 25 mM
DAPT, imaged at 3 dpf, and scored for the tail curvature
phenotype.
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g-Secretase Cleavage of PC1 Regulates TCF and CHOPHyperproliferation and increased apoptosis are characteristic
of ADPKD (Lanoix et al., 1996; Starremans et al., 2008).We found
that loss of Pkd1 in otherwise genetically identical cell lines
resulted in a significant increase in both proliferation and
apoptosis. These experiments were performed in vitro, thus
eliminating any potential effects of the cyst microenvironment
on the proliferative or apoptotic potential of the cyst-lining cells
that might complicate the situation in vivo. Thus, our data estab-
lish that the loss of expression of the Pkd1 gene product is
primarily responsible for the proliferative and apoptotic changes
seen in ADPKD.206 Developmental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc.Cleavage of the CTT of PC1 has been
observed in several studies (Bertuccio et al.,
2009; Chauvet et al., 2004; Lal et al., 2008;
Low et al., 2006), and its subsequent transloca-
tion to the nucleus strongly implies its role in the
regulation of transcriptional pathways. Although
the cleaved CTT fragment certainly does not
recapitulate all of the functions of full-length
PC1, our data suggest that the isolated CTT
is sufficient to reestablish normal low levels
of proliferation and apoptosis, and of TCF
and CHOP activity, when expressed in Pkd1
knockout cells. Furthermore, PC1-CTT is
capable of at least partially restoring to Pkd1
knockout cells the tubular morphology that is
obtained with wild-type and Pkd1 heterozygous
cells grown in 3D cell culture. Finally, our data
suggest that PC1 cleavage by g-secretase
may be necessary for PC1 to mediate its full
complement of physiological functions. Inhibit-
ing g-secretase activity causes PC1-expressing
cells that form tubular structures in 3D culture to
recapitulate the cystic morphology normally
manifest by Pkd1 null cells. It is possible, of
course, that g-secretase influences epithelial
morphogenesis in this assay via additional path-
ways that are independent of PC1. BecausePkd1/ cells were unaffected by DAPT treatment in both the
morphogenesis and the TCF and CHOP assays, however, we
conclude that g-secretase-mediated cleavage of PC1 plays an
obligate role in at least a subset of this protein’s physiological
functions.
The shedding of the extracellular domain of PC1 and the
cleavage and nuclear translocation of its cytoplasmic domain
together mark PC1 as a member of a growing collection of
plasma membrane proteins that is cleaved by g-secretase and
participates in direct signaling to the nucleus (Lal and Caplan,
2011). This behavior is exemplified by the Notch (Fortini, 2009),
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g-Secretase Cleavage of PC1 Regulates TCF and CHOPEpCAM (Maetzel et al., 2009), and DCC pathways (Taniguchi
et al., 2003). The precise site at which g-secretase cleaves
PC1-CTT has not yet been determined. It is worth noting,
however, that g-secretase appears to exhibit substantial
promiscuity in the sequence compositions of its substrate
cleavage sites (Beel and Sanders, 2008; Struhl and Adachi,
2000). This promiscuity may account, at least in part, for the
number of discrete PC1-CTT cleavage products that can be
detected in nuclear fractions (Figure 2B). The precise signals
that stimulate g-secretase-mediated cleavage of PC1 have yet
to be discovered.
We report a direct physical interaction between the PC1-CTT
and TCF. Lal et al. have suggested that the PC1-CTT inhibits
canonical Wnt signaling through an interaction with b-catenin
(Lal et al., 2008). Because these experiments assessed the coim-
munoprecipitation of epitope-tagged proteins coexpressed in
human cell lines, the recovered protein complexes may have
contained additional members of the signaling pathway, such
as TCF, that were not detected in immunoblots that assessed
only the presence of the tagged proteins. Thus, it seems likely
that the coprecipitation of the PC1-CCT and b-catenin observed
by Lal et al. (Lal et al., 2008) could be attributable to a mutual
interaction of both of these proteins with TCF to form an inactive
tertiary complex. The bacterial coexpression system utilized in
the present study allowed us to further dissect the canonical
Wnt pathway and to determine that TCF is a direct binding
partner of PC1-CTT. It should be noted that, while activation of
the Wnt-signaling pathway is sufficient to produce renal cystic
disease (Qian et al., 2005; Saadi-Kheddouci et al., 2001), and
markers of Wnt signaling appear to be elevated in the context
of human ADPKD (Lal et al., 2008), a recent study found that
the cyst-lining cells of mouse models of ADPKD that express
a Wnt/TCF reporter did not manifest elevated levels of Wnt
activity (Miller et al., 2011). Therefore, it is possible that activation
of Tcf-mediated transcription plays an early, transient role in the
initiation of cyst formation that is terminated by the time cysts are
manifest. It is also possible that pathways other than those
associated with Wnt/TCF drive the hyperproliferation that is
associated with the cystic epithelial cells in ADPKD. In either
case, our data demonstrate that cleavage of the PC1 generates
a protein that is both antiproliferative and sufficient to suppress
ADPKD-related phenotypes in vitro and in vivo.
The activities of both TCF and CHOP depend upon the
common transcriptional coactivator p300 (Li et al., 2007; Ohoka
et al., 2007). Our data suggest that PC1-CTT binds directly to the
transcription factors TCF and CHOP, and are consistent with the
hypothesis that PC1-CTT acts by blocking the p300 binding sites
on both TCF and CHOP. Therefore, the p300 protein constitutes
a promising convergence point that appears to be utilized by
PC1-CTT to regulate two distinct transcription factors. This regu-
lation of TCF and CHOP through interactions with the released
PC1-CTT provides a simple and compelling explanation for the
dysregulation of proliferation and apoptosis seen in ADPKD.EXPERIMENTAL PROCEDURES
Antibodies, Plasmids, and Cell Lines
The following antibodies and labeling reagents were used: a-HA antibody, Rat
(Roche), FITC a-BrdUKit (BDBioscience), a-cleaved caspase-3 (Cell SignalingDevelopmTechnology), a-RNA Pol II (Santa Cruz Biotechnology), a-calnexin (Strata-
gene), a-His (QIAGEN), a-GST (Amersham), and a-FLAG and a-cMyc
(Sigma-Aldrich). For laser-scanning fluorescence microscopy, dye-coupled
Alexa antibodies (Alexa 488, 594; Molecular Probes) were used as secondary
reagents.
The sequence encoding the final 200 amino acids of human PC1 (4102–
4302), containing a 23 HA tag at the N terminus, was cloned into the
pNRTis-21 vector (Tenev et al., 2000). The sequence for human PC1-CTT (resi-
dues 4102–4302 of Pkd1) was modified by deleting residues 4134–4154, cor-
responding to the putative NLS to generate the PC1-CTTDNLS (Chauvet et al.,
2004). Stable cell lines were generated by transfection using Lipofectamine
2000 (Invitrogen) and selection with 350 mg ml1 Zeocin (Invitrogen). Expres-
sion was inhibited with 100 ng ml1 doxycycline. Full-length human PC1
was cloned into pcDNA3.1.neo (Invitrogen) with 23 HA tag or Gal4VP16
appended to the C terminus as described (Bertuccio et al., 2009). Stable cell
clones were selected with 2 mg ml1 Geneticin (GIBCO). GL4.31[luc2P/
GAL4UAS] (Promega, Madison, WI, USA) was used as a Gal4 promoter-driven
firefly luciferase reporter construct. The TopFlash plasmid was purchased
from Upstate Biotechnology. pRL-TK, a vector constitutively expressing
Renilla luciferase, was included as an internal control to normalize for transfec-
tion differences. The sequence encoding the PC1-CTT was cloned into the
pETDuet vector with an N-terminal 6xHis tag, along with either the GST-
E-cadherin cytoplasmic domain, GST-b-catenin, or GST-TCF b-catenin
binding region (Gottardi and Gumbiner, 2004). The CHOP-Gal4 construct
was provided by Dr. John Hogenesch (Department of Pharmacology, Univer-
sity of Pennsylvania). The sequence encoding full-length CHOP was cloned
into the pCMV-3Tag-1A vector (Stratagene) to generate 3xFLAG-CHOP.
The sequence encoding human p300 (full-length or amino acid residues
1–664) was cloned into the pCMV-Tag 3B vector (Stratagene) to generate
Myc-p300.
HEK293T cells (Chauvet et al., 2004), LLC-PK1 cells, and Pkd1
flox/ and
Pkd1/ temperature-sensitive SV40 large T antigen renal proximal tubule
cells (Joly et al., 2006; Shibazaki et al., 2008) were maintained as described.
3D Cell Culture, a-BrdU Staining, and Cell Counting
Pkd1flox/, Pkd1/, and Pkd1/ stably expressing pNRTis HA-PC1-CTT
were trypsinized and mixed with 300 ml liquid Matrigel (BD Biosciences) and
allowed to solidify for 30 min at 37C, after which media were added with or
without 100 ng ml1 doxycycline, and the cells were grown for 7–10 days.
These cell lines were grown on coverslips in parallel for quantification of prolif-
eration and apoptosis.
BrdU was added to the media for 90 min prior to fixation. Cells grown on
coverslips were stained as per BD protocol. Cells grown in Matrigel were fixed
for 1.5 hr at 37C, permeabilized for 30 min at 4C, refixed for 15 min at RT,
treated with DNase for 3 hr at 37C, incubated with the a-BrdU 1Ab (1:100)
for 5 days at 4C, followed by three 2 hr washes, and by incubation for
1 day with 2Ab (1:200); nuclei were stained with Hoechst 33342 (Molecular
Probes).
Cells grown on coverslips were imaged using an Olympus BX51 epifluores-
cent microscope equipped with a 203 objective. The percentages of BrdU or
caspase-3-positive cells were quantified using a threshold method in conjunc-
tion with the ImageJ software package plug-in ‘‘Nucleus Counter.’’
The cross-sectional areas of the cell structures grown in 3D Matrigel culture
were calculated using ImageJ software. Cells were stained with a-BrdU, a-HA,
and Hoechst 33342 and imaged using anOlympus BX51 epifluorescent micro-
scope equipped with a 103 objective. Cell structures were thresholded from
background, and the cross-sectional area of each cell cluster was calculated
using the ImageJ Analyze Particles plug-in, with a minimum size cutoff of 50
pixels to filter out isolated cells and debris.
Cell Fractionation
Preparation of nuclear and cytoplasmic fractions was performed as previously
described (Chauvet et al., 2004). Cells grown in 10 cm dishes in the presence
of 25 mM clasto-lactacystin were harvested in cold PBS, centrifuged for
5 min at 500 3 g, and resuspended in hypotonic buffer (10 mM HEPES,
1.5 mMMgCl2, 10 mM KCl, and protease inhibitors). Cells were homogenized
in a tight-fitting Dounce homogenizer, chilled on ice for 10 min, and then
rotated for 15 min. Nonidet P-40 was added to a final concentration of 1%,ental Cell 22, 197–210, January 17, 2012 ª2012 Elsevier Inc. 207
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were centrifuged at 1,500 3 g for 5 min. The resulting supernatant formed
the nonnuclear fractions. The pellets (nuclear fractions) were washed in
hypotonic buffer for 10 min, resuspended in lysis buffer (50 mM HEPES [pH
7.4], 200 mM NaCl, 0.5% NP-40, 1 mM EDTA, and protease inhibitors), and
rotated for 10 min. Pelleted nuclei were lysed by sonication in lysis buffer and
prepared for immunoblot analysis. The protein concentration of each sample
was determined using a Bio-Rad colorimetric protein concentration assay.
Coactivator Trap Screen
The coactivator trap screen was performed as previously described (Amelio
et al., 2007). A pcDNA3.1 construct expressing HA-PC1-CTT was cotrans-
fected with each of 837 transcription factor-Gal4 fusion proteins and the GAL4
luciferase and Renilla reporter plasmids into HEK293Tcells in a 384-well plate.
Cells were cultured for 24 hr in a humidified incubator at 37C in 5% CO2.
Bright-Glo (Promega) reagent (35 ml) was added to each well, and luciferase
luminescence was measured with an Acquest plate reader (LJL Biosystems).
Transient Transfection and Luciferase Assay
Pkd1flox/ cells, Pkd1/ cells, and Pkd1/ cells stably expressing pNRTis
HA-PC1-CTTwere plated in 24-well tissue culture plates and transfected using
Lipofectamine 2000 (Invitrogen) at 80%–100%confluency. Luciferase reporter
constructs TopFlash or GL4.31[luc2P/GAL4UAS] (0.2 mg), and CHOP-Gal4
(0.05 mg) and pRL-TK (Renilla), were mixed with 2 ml Lipofectamine. HEK293
cells were transfected with STAT6-Luciferase (kind gift of Dr. S.J. Hacque,
Cleveland Clinic Foundation) (Haque et al., 1997) or with TopFlash-luciferase,
or with CHOP-Gal4/Gal4-luciferase (0.2 mg), as well as with either control
plasmid, STAT6-V5, HA-PC1-CTT or HA-PC1-CTTDNLS, and with pRL-TK
(Renilla). Transfection mixtures were added drop wise to cell culture media
(containing 80 mM DAPT [Sigma-Aldrich] when indicated) and incubated at
37C for 24 hr. The amount of DNA in each well was equalized through the
addition of a control plasmid, pcDNA3.1, which was also used for mock trans-
fection. Transfected cells were harvested with PBS and lysed with 100 ml of
passive lysis buffer (Promega). Luciferase levels were assayed using the
Dual Luciferase Assay Reagent kit (Promega). Luciferase signals were deter-
mined in a GloMax 20/20 luminometer (Promega).
siRNA Treatment
HEK293 cells were transfected with 100 nM target-specific siRNA or control
siRNA using Lipofectamine 2000. As a control siRNA, we used Silencer Nega-
tive Control siRNA#1 (#AM4611; Ambion). To knock down PSEN1 and PSEN2,
we used validated siRNAs (for PSEN1, SI02662688 from QIAGEN; for PSEN2,
AM51331 from Ambion). Knockdown of CHOP was accomplished according
a published protocol (Ishikawa et al., 2009).
Immunoprecipitation, Immunoblot, and GST Pull-Down
Cells were lysed by sonication in 50 mM HEPES (pH 7.4), 150 mM NaCl, 0.5%
NP-40, 1 mM EDTA with protease inhibitors (Roche). Precleared lysates
(18,000 3 g, 30 min) were incubated at 4C overnight with either mono-
clonal-anti-HA agarose, anti-FLAG-M2 agarose (Sigma-Aldrich), or gluta-
thione-Sepharose 4B beads (Amersham) prebound with indicated GST fusion
protein constructs harvested from BL21 bacteria by standard procedures
(Stratagene). Beads were collected by centrifugation, and the pellets were
washed in lysis buffer three times for 10 min with rotation at 4C. Immunopre-
cipitates were eluted in SDS-PAGE loading buffer (25 mM Tris-HCl [pH 6.7],
10% glycerol, 1% SDS, 50 mM DTT, bromophenol blue).
Proteins were separated on a 10% SDS-polyacrylamide gel and then elec-
trophoretically transferred to a nitrocellulose membrane (Bio-Rad), incubated
in blocking buffer (150 mM NaCl, 20 mM Tris, 5% [w/v] powdered milk, 0.1%
Tween) for 60 min, and then incubated with one of the following primary anti-
bodies at 4C overnight: monoclonal a-HA (rat) antibody (1:5,000; Roche);
polyclonal a-FLAG (1:5,000; Sigma-Aldrich); polyclonal a-cMyc (1:5,000;
Sigma-Aldrich); polyclonal a-GST (goat) (1:10,000; Amersham); and a-His
(1:5,000; QIAGEN). Subsequently, primary antibody binding was detected
with horseradish peroxidase-conjugated anti-rat, anti-rabbit, or anti-goat
secondary antibodies (1:5,000–10:000; Jackson Labs), and proteins were
visualized with an enhanced chemiluminescence detection kit (ECL; Amer-
sham Biosciences).208 Developmental Cell 22, 197–210, January 17, 2012 ª2012 ElseviZebrafish Experiments: Morpholino Antisense Oligonucleotide
and mRNA Injections and Drug Treatment
Morpholino-induced knockdown of Pkd1a and Pkd1b expression was per-
formed as previously reported (Mangos et al., 2010). Wild-type embryos at
the one- to two-cell stage were microinjected with 4.6 nl of a 0.15 mM anti-
sensemorpholino oligonucleotide solution (Gene Tools LLC) with 0.1% phenol
red using a nanoject2000 microinjector (World Precision Instruments). The
sequences of the morpholinos targeting Pkd1a and Pkd1b were identical to
those that have been previously described (Mangos et al., 2010); briefly, the
splice donor-blocking oligonucleotide sequences were: Pkd1a MO ex8,
50-GATCTGAGGACTCACTGTGTGATTT-30; and Pkd1bMO ex45, 50-ACATGA
TATTTGTACCTCTTTGGTT-30. Gene Tools standard negative control morpho-
lino was used as an injection control and demonstrated no effect on develop-
ment. For drug treatment, after mRNA injection at the one- to two-cell stage,
embryos were placed in a 10 cm dish with 30 ml embryo media containing
25 mM DAPT dissolved in DMSO and imaged 3 dpf as described (Arslanova
et al., 2010).
Statistical Analysis
Results are expressed as means ± SE. Differences between means were eval-
uated using Student’s t test or analysis of variance as appropriate. Values of
p < 0.05 were considered to be significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and three movies
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